Complement C3 contributes to ethanol‐induced liver steatosis in mice

References

• Stewart S., Jones D., Day C. P. Alcoholic liver disease: new insights into mechanisms and preventative strategies. Trends Mol Med 2001; 7: 408–13
   PubMed Web of Science ®Google Scholar
• Schenker S., Bay M. K. Alcohol and endotoxin: another path to alcoholic liver injury?. Alcohol Clin Exp Res 1995; 19: 1364–6
   PubMed Web of Science ®Google Scholar
• Campbell W., Okada N., Okada H. Carboxypeptidase R is an inactivator of complement‐derived inflammatory peptides and an inhibitor of fibrinolysis. Immunol Rev 2001; 180: 162–7
   PubMed Web of Science ®Google Scholar
• Baldo A., Sniderman A. D., St‐Luce S., Avramoglu R. K., Maslowska M., Hoang B., et al. The adipsin‐acylation stimulating protein system and regulation of intracellular triglyceride synthesis. J Clin Invest 1993; 92: 1543–7
   PubMed Web of Science ®Google Scholar
• Cianflone K., Xia Z., Chen L. Y. Critical review of acylation‐stimulating protein physiology in humans and rodents. Biochim Biophys Acta 2003; 1609: 127
   PubMed Web of Science ®Google Scholar
• Persson L., Boren J., Robertson A. K., Wallenius V., Hansson G. K., Pekna M. Lack of complement factor C3, but not factor B, increases hyperlipidemia and atherosclerosis in apolipoprotein E−/− low‐density lipoprotein receptor−/− mice. Arterioscler Thromb Vasc Biol 2004; 24: 1062–7
   PubMedGoogle Scholar
• Murray I., Sniderman A. D., Cianflone K. Enhanced triglyceride clearance with intraperitoneal human acylation stimulating protein in C57BL/6 mice. Am J Physiol 1999; 277: E474–E480
   Google Scholar
• Strey C. W., Markiewski M., Mastellos D., Tudoran R., Spruce L. A., Greenbaum L. E., et al. The proinflammatory mediators C3a and C5a are essential for liver regeneration. J Exp Med 2003; 198: 913–23
   PubMed Web of Science ®Google Scholar
• Puschel G. P., Hespeling U., Oppermann M., Dieter P. Increase in prostanoid formation in rat liver macrophages (Kupffer cells) by human anaphylatoxin C3a. Hepatology 1993; 18: 1516–21
   PubMedGoogle Scholar
• Schieferdecker H. L., Rothermel E., Timmermann A., Gotze O., Jungermann K. Anaphylatoxin C5a receptor mRNA is strongly expressed in Kupffer and stellate cells and weakly in sinusoidal endothelial cells but not in hepatocytes of normal rat liver. FEBS Lett 1997; 406: 305–9
   PubMed Web of Science ®Google Scholar
• Ramaiah S., Rivera C., Arteel G. Early‐phase alcoholic liver disease: an update on animal models, pathology, and pathogenesis. Int J Toxicol 2004; 23: 217–31
   PubMed Web of Science ®Google Scholar
• Jarvelainen H. A., Fang C., Ingelman‐Sundberg M., Lukkari T. A., Sippel H., Lindros K. O. Kupffer cell inactivation alleviates ethanol‐induced steatosis and CYP2E1 induction but not inflammatory responses in rat liver. J Hepatol 2000; 32: 900–10
   PubMed Web of Science ®Google Scholar
• Jarvelainen H. A., Vakeva A., Lindros K. O., Meri S. Activation of complement components and reduced regulator expression in alcohol‐induced liver injury in the rat. Clin Immunol 2002; 105: 57–63
   PubMedGoogle Scholar
• Bykov I. L., Vakeva A., Jarvelainen H. A., Meri S., Lindros K. O. Protective function of complement against alcohol‐induced rat liver damage. Int Immunopharmaco 2004; 12: 1445–54
   Google Scholar
• Pekna M., Hietala M. A., Rosklint T., Betsholtz C., Pekny M. Targeted disruption of the murine gene coding for the third complement component (C3). Scand J Immunol 1998; 47: 25–9
   PubMedGoogle Scholar
• Bykov I., Palmen M., Piirainen L., Lindros K. O. Oral chronic ethanol administration to rodents by agar gel diet. Alcohol Alcohol 2004; 39: 499–502
   PubMedGoogle Scholar
• Lindros K. O., Jarvelainen H. A. A new oral low‐carbohydrate alcohol liquid diet producing liver lesions: a preliminary account. Alcohol Alcohol 1998; 3: 347–53
   Google Scholar
• Hu Y., Ingelman‐Sundberg M., Lindros K. O. Induction mechanisms of cytochrome P450 2E1 in liver: interplay between ethanol treatment and starvation. Biochem Pharmacol 1995; 50: 155–61
   PubMed Web of Science ®Google Scholar
• Ohkawa H., Ohishi N., Yagi K. Assay of lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351–58
   PubMed Web of Science ®Google Scholar
• Sissons J. G., West R. J., Fallows J., Williams D. G., Boucher B. J., Amos N., et al. The complement abnormalities of lipodystrophy. N Engl J Med 1976; 294: 461–5
   PubMed Web of Science ®Google Scholar
• Misra A., Peethambaram A., Garg A. Clinical features and metabolic and autoimmune derangements in acquired partial lipodystrophy: report of 35 cases and review of the literature. Medicine 2004; 83: 18–34
   PubMed Web of Science ®Google Scholar
• Homann C., Varming K., Hogasen K., Mollnes T. E., Graudal N., Thomsen A. C., et al. Acquired C3 deficiency in patients with alcoholic cirrhosis predisposes to infection and increased mortality. Gut 1997; 40: 544–9
   PubMed Web of Science ®Google Scholar